Immucell (ICCC) Income from Non-Controlling Interests (2020 - 2023)
Immucell's Income from Non-Controlling Interests came in at -$1.38 million for Q2 2023, compared with -$684,148 a year earlier.
Powered by 
Analysis
Immucell (ICCC) Income from Non-Controlling Interests (2020 - 2023) Analysis & Trends
Over the trailing twelve months to Jun 30, 2023, Immucell reported Income from Non-Controlling Interests of -$6.02 million; for FY2022, it came in at -$2.49 million.
- Going back by year, Income from Non-Controlling Interests was -$78,292 in FY2021 and -$1.02 million in FY2020.
- The five-year range for quarterly Income from Non-Controlling Interests is -$2.32 million (Q1 2023) to $513,287 (Q1 2022).
- Business Quant data shows ICCC's Income from Non-Controlling Interests at -$2.32 million (Q1 2023), -$1.67 million (Q4 2022) and -$655,078 (Q3 2022) in the three quarters before Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,128.85 Bn | 1,097.43 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 634.21 Bn | 554.07 Bn | 17.30 Bn | - |
| 3 | AbbVie | 505.78 Bn | 478.89 Bn | 12.70 Bn | 3.00 Mn |
| 4 | Merck | 357.64 Bn | 312.02 Bn | 12.21 Bn | -2.00 Mn |
| 5 | Novartis Ag | 290.31 Bn | 254.30 Bn | 11.24 Bn | -7.00 Mn |
| 6 | Astrazeneca | 265.38 Bn | 239.06 Bn | 12.86 Bn | 1.00 Mn |
| 7 | Amgen | 238.11 Bn | 193.51 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.79 Bn | 168.99 Bn | 6.22 Bn | - |
| 9 | Pfizer | 171.11 Bn | 117.76 Bn | 10.94 Bn | 10.00 Mn |
| 10 | Immucell | 93.00 Mn | 70.45 Mn | 2.44 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -1.38 Mn |
| Mar 31, 2023 | -2.32 Mn |
| Dec 31, 2022 | -1.67 Mn |
| Sep 30, 2022 | -655,078.00 |
| Jun 30, 2022 | -684,148.00 |
| Mar 31, 2022 | 513,287.00 |
| Dec 31, 2021 | 74,134.00 |
| Sep 30, 2021 | 147,764.00 |
| Jun 30, 2021 | 141,113.00 |
| Mar 31, 2021 | -441,303.00 |
| Dec 31, 2020 | 188,830.00 |
| Sep 30, 2020 | -322,888.00 |
| Jun 30, 2020 | -765,793.00 |
API Access
Immucell Income from Non-Controlling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=ICCC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "ICCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=ICCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();